X0206 3 2022-10-03 0 0001367083 Sonoma Pharmaceuticals, Inc. SNOA 0001949607 White Chad Norman C/O SONOMA PHARMACEUTICALS, INC. 645 MOLLY LANE, SUITE 150 WOODSTOCK GA 30189 0 1 0 0 Interim CFO Stock Option (right to buy) 2.21 2032-10-03 Common Stock 5000 D The Issuer granted the options as an initial grant upon Mr. White's appointment as interim Chief Financial Officer of the Issuer. The options vest in three equal tranches annually on the grant date anniversary, beginning on October 3, 2023 and becoming fully vested on October 3, 2025, or upon change of control of the Issuer. /s/ Chad N. White 2022-10-12